|
| |
Thrombotargets inaugurates new facilities at the National Biotechnology
Centre (CNB) in Madrid, Spain
Thrombotargets Europe increases its R&D potential by inaugurating a new
research laboratory at the National Biotechnology Centre (CNB) in Madrid.
As part of the strategic collaborations between Thrombotargets Europe S.L.(
www.thrombotargets.com ) and Public
Research Institutions, Thrombotargets Europe has reached an agreement with the
CNB, belonging to the Spanish Research Council (CSIC), to have access to a
research laboratory located at the new CNB-annex building designed for the
purpose of starting-up biotech initiatives.
The new 2500 square feet laboratory will be operative on the second week of
February 2007 and will envisage the future growth of the company for the next
three years. CNB offers to Thrombotargets Europe research team a full access to
the most advanced facilities, such as proteomic and genomic services, protein
design, protein tools, electron microscopy, transgenesis and animal facilities (
www.cnb.uam.es ). In addition, this
agreement will facilitate further interaction of Thrombotargets Europe members
with the research activities of one of the most advanced biotech institutes in
Europe.
The potential of this new research laboratory in cooperation with tha already
existing facilities in Barcelona will provide Thrombotargets the capability to
undertake research projects from drug discovery to clinical trials.
Contact
Luis Caveda
Chief Operating Officer
luiscaveda@thrombotargets.com
| |
|
